Insulet (PODD) EBITDA Margin (2010 - 2026)
Insulet's EBITDA Margin was 19.51% in Q2 2026, down 2.58 percentage points from 22.09% a year earlier but up 0.04 percentage points from the prior quarter.
Powered by 
Analysis
Insulet (PODD) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Insulet's EBITDA Margin was 20.14% through Jun 30, 2026, down 0.80 percentage points year-over-year; for FY2025, it came in at 20.83%, up 2.02 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +9.01 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 18.81% in FY2024 (+1.55 pp), 17.26% in FY2023 (+9.54 pp), 7.72% in FY2022 (-8.97 pp) and 16.69% in FY2021 (+4.87 pp).
- Quarterly EBITDA Margin has moved between -3.64% (Q2 2022) and 24.58% (Q4 2023) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +0.84 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2023 (a gain of 16.05 percentage points); the worst was Q2 2022 (a drop of 19.41 percentage points).
- Per Business Quant data, PODD's EBITDA Margin in the three quarters before Q2 2026 was 19.47% (Q1 2026), 21.78% (Q4 2025) and 19.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 31.93% |
| 10 | Insulet | 9.83 Bn | 7.34 Bn | 562.60 Mn | 19.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.60% |
| Mar 31, 2026 | 19.56% |
| Dec 31, 2025 | 21.88% |
| Sep 30, 2025 | 19.89% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | 19.86% |
| Dec 31, 2024 | 22.21% |
| Sep 30, 2024 | 20.41% |
| Jun 30, 2024 | 15.46% |
| Mar 31, 2024 | 17.59% |
| Dec 31, 2023 | 24.99% |
| Sep 30, 2023 | 17.36% |
| Jun 30, 2023 | 12.71% |
| Mar 31, 2023 | 12.96% |
| Dec 31, 2022 | 11.14% |
| Sep 30, 2022 | 5.84% |
| Jun 30, 2022 | -3.31% |
| Mar 31, 2022 | 18.52% |
| Dec 31, 2021 | 23.69% |
| Sep 30, 2021 | 17.82% |
API Access
Insulet EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PODD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PODD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PODD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();